{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:44:51Z","timestamp":1762299891223,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"japan society for the promotion of science","doi-asserted-by":"publisher","award":["21K15264"],"award-info":[{"award-number":["21K15264"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"japan agency for medical research and development","doi-asserted-by":"publisher","award":["21mk0101214"],"award-info":[{"award-number":["21mk0101214"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008731","name":"nakatomi foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012359","name":"promotion and mutual aid corporation for private schools of japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005405","name":"ritsumeikan university","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00204-021-03175-0","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T13:32:35Z","timestamp":1634391155000},"page":"499-510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Generation of Caco-2 cells stably expressing CYP3A4\u00b7POR\u00b7UGT1A1 and\u00a0CYP3A4\u00b7POR\u00b7UGT1A1*6\u00a0using a PITCh system"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6567-575X","authenticated-orcid":false,"given":"Ryosuke","family":"Negoro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,16]]},"reference":[{"key":"3175_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1359-6446(04)03354-9","volume":"10","author":"PV Balimane","year":"2005","unstructured":"Balimane PV, Chong S (2005) Cell culture-based models for intestinal permeability: a critique. Drug Discov Today 10:335\u2013343. https:\/\/doi.org\/10.1016\/S1359-6446(04)03354-9","journal-title":"Drug Discov Today"},{"key":"3175_CR2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00280-014-2382-3","volume":"73","author":"L Cheng","year":"2014","unstructured":"Cheng L, Li M, Hu J et al (2014) UGT1A1*6 polymorphisms are correlated with irinotecan-induced toxicity: a system review and meta-analysis in Asians. Cancer Chemother Pharmacol 73:551\u2013560. https:\/\/doi.org\/10.1007\/s00280-014-2382-3","journal-title":"Cancer Chemother Pharmacol"},{"key":"3175_CR3","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1023\/A:1016428304366","volume":"13","author":"CL Crespi","year":"1996","unstructured":"Crespi CL, Bruce W, Penman MH (1996) Development of Caco-2 cells expressing high levels of cDNA derived CYP3A4.pdf. Pharm Res 13:1635\u20131641","journal-title":"Pharm Res"},{"key":"3175_CR4","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1023\/A:1010914624111","volume":"18","author":"CL Cummins","year":"2001","unstructured":"Cummins CL, Mangravite LM, Benet LZ (2001) Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Pharm Res 18:1102\u20131109. https:\/\/doi.org\/10.1023\/A:1010914624111","journal-title":"Pharm Res"},{"key":"3175_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1124\/jpet.103.058065","volume":"308","author":"CL Cummins","year":"2004","unstructured":"Cummins CL, Jacobsen W, Christians U, Benet LZ (2004) CYP3A4-transfected Caco-2 cells as a tool for understanding biochemical absorption barriers: studies with sirolimus and midazolam. J Pharmacol Exp Ther 308:143\u2013155. https:\/\/doi.org\/10.1124\/jpet.103.058065","journal-title":"J Pharmacol Exp Ther"},{"key":"3175_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/fcp.12117","volume":"29","author":"M-C Etienne-Grimaldi","year":"2015","unstructured":"Etienne-Grimaldi M-C, Boyer J-C, Thomas F et al (2015) UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice. Fundam Clin Pharmacol 29:219\u2013237. https:\/\/doi.org\/10.1111\/fcp.12117","journal-title":"Fundam Clin Pharmacol"},{"key":"3175_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1517\/17425255.4.4.381","volume":"4","author":"D Farkas","year":"2008","unstructured":"Farkas D, Greenblatt DJ (2008) Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies. Expert Opin Drug Metab Toxicol 4:381\u2013393. https:\/\/doi.org\/10.1517\/17425255.4.4.381","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3175_CR8","doi-asserted-by":"publisher","first-page":"12234","DOI":"10.3748\/wjg.v21.i43.12234","volume":"21","author":"K Fujita","year":"2015","unstructured":"Fujita K, Kubota Y, Ishida H, Sasaki Y (2015) Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer. World J Gastroenterol 21:12234\u201312248. https:\/\/doi.org\/10.3748\/wjg.v21.i43.12234","journal-title":"World J Gastroenterol"},{"key":"3175_CR9","first-page":"766","volume":"28","author":"LQ Guo","year":"2000","unstructured":"Guo LQ, Fukuda K, Ohta T, Yamazoe Y (2000) Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab Dispos 28:766\u2013771","journal-title":"Drug Metab Dispos"},{"key":"3175_CR10","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1023\/a:1018986605929","volume":"16","author":"M Hu","year":"1999","unstructured":"Hu M, Li Y, Davitt CM et al (1999) Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase. Pharm Res 16:1352\u20131359. https:\/\/doi.org\/10.1023\/a:1018986605929","journal-title":"Pharm Res"},{"key":"3175_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.omtm.2021.01.005","volume":"20","author":"M Ichikawa","year":"2021","unstructured":"Ichikawa M, Negoro R, Kawai K et al (2021) Vinblastine treatment decreases the undifferentiated cell contamination of human iPSC-derived intestinal epithelial-like cells. Mol Ther Methods Clin Dev 20:463\u2013472. https:\/\/doi.org\/10.1016\/j.omtm.2021.01.005","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3175_CR12","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1124\/dmd.118.082123","volume":"46","author":"T Kabeya","year":"2018","unstructured":"Kabeya T, Qiu S, Hibino M et al (2018) Cyclic AMP signaling promotes the differentiation of human induced pluripotent stem cells into intestinal epithelial cells. Drug Metab Dispos 46:1411\u20131419. https:\/\/doi.org\/10.1124\/dmd.118.082123","journal-title":"Drug Metab Dispos"},{"key":"3175_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1124\/dmd.104.001800","volume":"33","author":"N Kaniwa","year":"2005","unstructured":"Kaniwa N, Kurose K, Jinno H et al (2005) Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C> T (P229L) found in an African-American. Drug Metab Dispos 33:458\u2013465. https:\/\/doi.org\/10.1124\/dmd.104.001800","journal-title":"Drug Metab Dispos"},{"key":"3175_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.omtm.2019.11.008","volume":"17","author":"K Kawai","year":"2020","unstructured":"Kawai K, Negoro R, Ichikawa M et al (2020) Establishment of SLC15A1\/PEPT1-knockout human-induced pluripotent stem cell line for intestinal drug absorption studies. Mol Ther Methods Clin Dev 17:49\u201357. https:\/\/doi.org\/10.1016\/j.omtm.2019.11.008","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3175_CR15","first-page":"99","volume":"8","author":"GE Lim","year":"2003","unstructured":"Lim GE, Li T, Buttar HS (2003) Interactions of grapefruit juice and cardiovascular medications: a potential risk of toxicity. Exp Clin Cardiol 8:99\u2013107","journal-title":"Exp Clin Cardiol"},{"key":"3175_CR16","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1172\/JCI119439","volume":"99","author":"KS Lown","year":"1997","unstructured":"Lown KS, Bailey DG, Fontana RJ et al (1997) Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 99:2545\u20132553. https:\/\/doi.org\/10.1172\/JCI119439","journal-title":"J Clin Invest"},{"key":"3175_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/03602530600739835","volume":"38","author":"S Nagar","year":"2006","unstructured":"Nagar S, Blanchard RL (2006) Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan. Drug Metab Rev 38:393\u2013409. https:\/\/doi.org\/10.1080\/03602530600739835","journal-title":"Drug Metab Rev"},{"key":"3175_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms6560","volume":"5","author":"S Nakade","year":"2014","unstructured":"Nakade S, Tsubota T, Sakane Y et al (2014) Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR\/Cas9. Nat Commun 5:1\u20138. https:\/\/doi.org\/10.1038\/ncomms6560","journal-title":"Nat Commun"},{"key":"3175_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbrc.2016.03.012","volume":"472","author":"R Negoro","year":"2016","unstructured":"Negoro R, Takayama K, Nagamoto Y et al (2016) Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cells. Biochem Biophys Res Commun 472:631\u2013636. https:\/\/doi.org\/10.1016\/j.bbrc.2016.03.012","journal-title":"Biochem Biophys Res Commun"},{"key":"3175_CR20","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.stemcr.2018.10.019","volume":"11","author":"R Negoro","year":"2018","unstructured":"Negoro R, Takayama K, Kawai K et al (2018) Efficient generation of small intestinal epithelial-like cells from human iPSCs for drug absorption and metabolism studies. Stem Cell Reports 11:1539\u20131550. https:\/\/doi.org\/10.1016\/j.stemcr.2018.10.019","journal-title":"Stem Cell Reports"},{"key":"3175_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.dmpk.2020.01.009","volume":"35","author":"R Negoro","year":"2020","unstructured":"Negoro R, Kawai K, Ichikawa M et al (2020) Establishment of MDR1-knockout human induced pluripotent stem cell line. Drug Metab Pharmacokinet 35:288\u2013296. https:\/\/doi.org\/10.1016\/j.dmpk.2020.01.009","journal-title":"Drug Metab Pharmacokinet"},{"key":"3175_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00228-016-2137-7","volume":"73","author":"Y-L Nie","year":"2017","unstructured":"Nie Y-L, He H, Li J-F et al (2017) Hepatic expression of transcription factors affecting developmental regulation of UGT1A1 in the Han Chinese population. Eur J Clin Pharmacol 73:29\u201337. https:\/\/doi.org\/10.1007\/s00228-016-2137-7","journal-title":"Eur J Clin Pharmacol"},{"key":"3175_CR23","doi-asserted-by":"publisher","first-page":"16479","DOI":"10.1038\/srep16479","volume":"5","author":"T Ozawa","year":"2015","unstructured":"Ozawa T, Takayama K, Okamoto R et al (2015) Generation of enterocyte-like cells from human induced pluripotent stem cells for drug absorption and metabolism studies in human small intestine. Sci Rep 5:16479. https:\/\/doi.org\/10.1038\/srep16479","journal-title":"Sci Rep"},{"key":"3175_CR24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1006\/bbrc.2000.3064","volume":"273","author":"MF Paine","year":"2000","unstructured":"Paine MF, Fisher MB (2000) Immunochemical identification of UGT isoforms in human small bowel and in caco-2 cell monolayers. Biochem Biophys Res Commun 273:1053\u20131057. https:\/\/doi.org\/10.1006\/bbrc.2000.3064","journal-title":"Biochem Biophys Res Commun"},{"key":"3175_CR25","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00204-008-0332-8","volume":"82","author":"O Pelkonen","year":"2008","unstructured":"Pelkonen O, Turpeinen M, Hakkola J et al (2008) Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol 82:667\u2013715. https:\/\/doi.org\/10.1007\/s00204-008-0332-8","journal-title":"Arch Toxicol"},{"key":"3175_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s40262-015-0351-6","volume":"55","author":"SA Peters","year":"2016","unstructured":"Peters SA, Jones CR, Ungell A-L, Hatley OJD (2016) Predicting drug extraction in the human gut wall: assessing contributions from drug metabolizing enzymes and transporter proteins using preclinical models. Clin Pharmacokinet 55:673\u2013696. https:\/\/doi.org\/10.1007\/s40262-015-0351-6","journal-title":"Clin Pharmacokinet"},{"key":"3175_CR27","first-page":"634","volume":"24","author":"T Prueksaritanont","year":"1996","unstructured":"Prueksaritanont T, Gorham LM, Hochman JH et al (1996) Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metab Dispos 24:634\u2013642","journal-title":"Drug Metab Dispos"},{"key":"3175_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.clpt.2004.01.010","volume":"75","author":"K Sai","year":"2004","unstructured":"Sai K, Saeki M, Saito Y et al (2004) UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer. Clin Pharmacol Ther 75:501\u2013515. https:\/\/doi.org\/10.1016\/j.clpt.2004.01.010","journal-title":"Clin Pharmacol Ther"},{"key":"3175_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/srep05400","volume":"4","author":"T Sakuma","year":"2014","unstructured":"Sakuma T, Nishikawa A, Kume S et al (2014) Multiplex genome engineering in human cells using all-in-one CRISPR\/Cas9 vector system. Sci Rep 4:4\u20139. https:\/\/doi.org\/10.1038\/srep05400","journal-title":"Sci Rep"},{"key":"3175_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nprot.2015.140","volume":"11","author":"T Sakuma","year":"2016","unstructured":"Sakuma T, Nakade S, Sakane Y et al (2016) MMEJ-Assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems. Nat Protoc 11:118\u2013133. https:\/\/doi.org\/10.1038\/nprot.2015.140","journal-title":"Nat Protoc"},{"key":"3175_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1517\/17425255.4.4.395","volume":"4","author":"H Sun","year":"2008","unstructured":"Sun H, Chow EC, Liu S et al (2008) The Caco-2 cell monolayer: usefulness and limitations. Expert Opin Drug Metab Toxicol 4:395\u2013411. https:\/\/doi.org\/10.1517\/17425255.4.4.395","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3175_CR32","doi-asserted-by":"publisher","first-page":"16772","DOI":"10.1073\/pnas.1413481111","volume":"111","author":"K Takayama","year":"2014","unstructured":"Takayama K, Morisaki Y, Kuno S et al (2014) Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes. Proc Natl Acad Sci 111:16772\u201316777. https:\/\/doi.org\/10.1073\/pnas.1413481111","journal-title":"Proc Natl Acad Sci"},{"key":"3175_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jcmgh.2019.06.004","volume":"8","author":"K Takayama","year":"2019","unstructured":"Takayama K, Negoro R, Yamashita T et al (2019) Generation of human iPSC-derived intestinal epithelial cell monolayers by CDX2 transduction. Cell Mol Gastroenterol Hepatol 8:513\u2013526. https:\/\/doi.org\/10.1016\/j.jcmgh.2019.06.004","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3175_CR34","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1124\/dmd.114.059493","volume":"42","author":"T Takenaka","year":"2014","unstructured":"Takenaka T, Harada N, Kuze J et al (2014) Human small intestinal epithelial cells differentiated from adult intestinal stem cells as a novel system for predicting oral drug absorption in humans. Drug Metab Dispos 42:1947\u20131954. https:\/\/doi.org\/10.1124\/dmd.114.059493","journal-title":"Drug Metab Dispos"},{"key":"3175_CR35","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.xphs.2015.11.035","volume":"105","author":"T Takenaka","year":"2016","unstructured":"Takenaka T, Harada N, Kuze J et al (2016) Application of a human intestinal epithelial cell monolayer to the prediction of oral drug absorption in humans as a superior alternative to the Caco-2 cell monolayer. J Pharm Sci 105:915\u2013924. https:\/\/doi.org\/10.1016\/j.xphs.2015.11.035","journal-title":"J Pharm Sci"},{"key":"3175_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.dmpk.2016.08.004","volume":"32","author":"T Takenaka","year":"2017","unstructured":"Takenaka T, Kazuki K, Harada N et al (2017) Development of Caco-2 cells co-expressing CYP3A4 and NADPH-cytochrome P450 reductase using a human artificial chromosome for the prediction of intestinal extraction ratio of CYP3A4 substrates. Drug Metab Pharmacokinet 32:61\u201368. https:\/\/doi.org\/10.1016\/j.dmpk.2016.08.004","journal-title":"Drug Metab Pharmacokinet"},{"key":"3175_CR37","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/jps.10050","volume":"91","author":"S Yamashita","year":"2002","unstructured":"Yamashita S, Konishi K, Yamazaki Y et al (2002) New and better protocols for a short-term Caco-2 cell culture system. J Pharm Sci 91:669\u2013679. https:\/\/doi.org\/10.1002\/jps.10050","journal-title":"J Pharm Sci"},{"key":"3175_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.stemcr.2020.12.017","volume":"16","author":"S Yoshida","year":"2021","unstructured":"Yoshida S, Honjo T, Iino K et al (2021) Generation of human-induced pluripotent stem cell-derived functional enterocyte-like cells for pharmacokinetic studies. Stem Cell Rep 16:295\u2013308. https:\/\/doi.org\/10.1016\/j.stemcr.2020.12.017","journal-title":"Stem Cell Rep"},{"key":"3175_CR39","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2165\/11318070-000000000-00000","volume":"48","author":"S-F Zhou","year":"2009","unstructured":"Zhou S-F (2009) Polymorphism of human cytochrome P450 2D6 and its clinical significance. Clin Pharmacokinet 48:761\u2013804. https:\/\/doi.org\/10.2165\/11318070-000000000-00000","journal-title":"Clin Pharmacokinet"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-03175-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-021-03175-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-03175-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T09:03:43Z","timestamp":1644570223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-021-03175-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,16]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["3175"],"URL":"https:\/\/doi.org\/10.1007\/s00204-021-03175-0","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"type":"print","value":"0340-5761"},{"type":"electronic","value":"1432-0738"}],"subject":[],"published":{"date-parts":[[2021,10,16]]},"assertion":[{"value":"1 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}